Insulin Management

Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 unit per kg, or as replacement, starting at 0.6 to 1.0 unit per kg. Glucose control, adverse effects, cost, adherence, and quality of life need to be considered when choosing therapy. Metformin should be continued if possible because it is proven to reduce all-cause mortality and cardiovascular events in overweight patients with diabetes. Titration of insulin over time is critical to improving glycemic control and preventing diabetes-related complications.

  • Diabetes and Insulin
  • Insulin Management of Type 2 Diabetes Mellitus
  • Insulin Therapy
  • Insulin with Oral Medications
  • Insulin Injection Technique
  • Types of insulin treat diabetes
  • Postprandial Hyperglycemia

Related Conference of Insulin Management

October 30- November 1, 2017

9th Annual Congress on Endocrine Disorders and Therapies


(10 Plenary Forums - 1 Event)
Chicago, Illinois, USA
October 30-November 01, 2017

10th International Conference on Endocrinology

Chicago, Illinois, USA
December 04-05, 2017

25th Global Diabetes Summit and Medicare Expo

Dubai, UAE
February 12-13,2018

7th European Diabetes and Endocrinology Congress

Munich, Germany
March 8-9, 2018

17th Global Diabetes Conference & Nursing Care

| Paris, France
May 23-24, 2018

11th Diabetologists Conference

New York, USA
June 11-12, 2018

27th European Diabetes Congress

| Rome, Italy
July 9-11, 2018 Sydney, Australia

20th Asia Pacific Diabetes Conference

August 20-22, 2018

28th World Congress on Diabetes, Obesity & Heart

Tokyo, Japan
September 03-04, 2018

2nd International Conference on Thyroid and Pregnancy

Auckland, New Zealand
September 3-5, 2018

11th World Congress on Endocrinology and Metabolic Disorders

Auckland, New Zealand

Insulin Management Conference Speakers